Article
Mesenchyme-specific loss of Dot1L histone methyltransferase leads to skeletal dysplasia phenotype in mice.
Bone - 1 Jan 2021
Sutter Pearl A, Karki Sangita, Crawley Ilan, Singh Vijender, Bernt Kathrin M, Rowe David W, Crocker Stephen J, Bayarsaihan Dashzeveg, Guzzo Rosa M
Abstract excerpt
Chromatin modifying enzymes play essential roles in skeletal development and bone maintenance, and deregulation of epigenetic mechanisms can lead to skeletal growth and malformation disorders. Here, we report a novel skeletal dysplasia phenotype in mice with conditional loss of Disruptor of telomeric silencing 1-like (Dot1L) histone methyltransferase in limb mesenchymal progenitors and downstream descendants....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
